{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-019112","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2021-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.521543+00:00","generated_at":"2026-06-29T16:18:56.939197+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stereotaxis Q2 revenue $9.1M (+70% YoY); sees system revenue doubling in 2022","bullets":["Revenue up ~70% YoY to $9.1M; system revenue $2.7M, recurring $6.1M.","Operating loss $3.4M, net loss $1.2M; adjusted net income $1.6M excluding stock comp.","Cash $44.2M; free cash flow negative $0.1M vs negative $1.2M prior year.","Received two robotic system orders (U.S. and Beijing); expects ~$11M system revenue in 2021.","Guidance: system revenue doubling in 2022; magnetic ablation catheter regulatory submissions in early 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-019112","json":"https://secwatch.observer/filing/0001493152-21-019112.json","markdown":"https://secwatch.observer/filing/0001493152-21-019112.md","text":"https://secwatch.observer/filing/0001493152-21-019112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000149315221019112/0001493152-21-019112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000149315221019112/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T16:18:56.939197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}